Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 580

1.

Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.

Divella R, Daniele A, Savino E, Palma F, Bellizzi A, Giotta F, Simone G, Lioce M, Quaranta M, Paradiso A, Mazzocca A.

Anticancer Res. 2013 Apr;33(4):1491-7.

PMID:
23564790
2.

The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer.

Divella R, Daniele A, Abbate I, Bellizzi A, Savino E, Simone G, Giannone G, Giuliani F, Fazio V, Gadaleta-Caldarola G, Gadaleta CD, Lolli I, Sabbà C, Mazzocca A.

Cancer Causes Control. 2014 Nov;25(11):1531-41. doi: 10.1007/s10552-014-0457-4. Epub 2014 Aug 19.

PMID:
25135616
3.
4.

Detection of circulating tumor cells in the context of treatment: prognostic value in breast cancer.

Serrano MJ, Sánchez-Rovira P, Delgado-Rodriguez M, Gaforio JJ.

Cancer Biol Ther. 2009 Apr;8(8):671-5. Epub 2009 Apr 8.

PMID:
19242121
5.

Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients.

Ivanović V, Demajo M, Krtolica K, Krajnović M, Konstantinović M, Baltić V, Prtenjak G, Stojiljković B, Breberina M, Nesković-Konstantinović Z, Nikolić-Vukosavljević D, Dimitrijević B.

Clin Chim Acta. 2006 Sep;371(1-2):191-3. Epub 2006 Feb 28.

PMID:
16650397
6.

Detection of circulating tumor cells in metastatic breast cancer patients.

Sanislo L, Vertakova-Krakovska B, Kuliffay P, Brtko J, Galbava A, Galbavy S.

Endocr Regul. 2011 Jul;45(3):113-24.

PMID:
21793623
7.

Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.

Tokudome N, Ito Y, Takahashi S, Kobayashi K, Taira S, Tsutsumi C, Oto M, Oba M, Inoue K, Kuwayama A, Masumura K, Nakayama Y, Watanabe C, Hatake K.

Breast Cancer. 2011 Jul;18(3):195-202. doi: 10.1007/s12282-011-0259-4. Epub 2011 Apr 5.

PMID:
21465230
8.

Serum levels of transforming growth factor beta1 in patients with breast cancer.

Sheen-Chen SM, Chen HS, Sheen CW, Eng HL, Chen WJ.

Arch Surg. 2001 Aug;136(8):937-40.

PMID:
11485532
9.

Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?

Dawood S, Broglio K, Valero V, Reuben J, Handy B, Islam R, Jackson S, Hortobagyi GN, Fritsche H, Cristofanilli M.

Cancer. 2008 Nov 1;113(9):2422-30. doi: 10.1002/cncr.23852.

10.

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.

Wülfing P, Borchard J, Buerger H, Heidl S, Zänker KS, Kiesel L, Brandt B.

Clin Cancer Res. 2006 Mar 15;12(6):1715-20.

11.

Screening of circulating TGF-β levels and its clinicopathological significance in human breast cancer.

Panis C, Herrera AC, Victorino VJ, Aranome AM, Cecchini R.

Anticancer Res. 2013 Feb;33(2):737-42.

PMID:
23393376
12.

[Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].

Cai QQ, Huang HQ, Lin TX, Jiang WQ.

Ai Zheng. 2005 Jul;24(7):837-41. Chinese.

PMID:
16004811
13.

Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.

Munzone E, Botteri E, Sandri MT, Esposito A, Adamoli L, Zorzino L, Sciandivasci A, Cassatella MC, Rotmensz N, Aurilio G, Curigliano G, Goldhirsch A, Nolè F.

Clin Breast Cancer. 2012 Oct;12(5):340-6. doi: 10.1016/j.clbc.2012.07.001.

PMID:
23040002
14.

Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.

Hiraiwa K, Takeuchi H, Hasegawa H, Saikawa Y, Suda K, Ando T, Kumagai K, Irino T, Yoshikawa T, Matsuda S, Kitajima M, Kitagawa Y.

Ann Surg Oncol. 2008 Nov;15(11):3092-100. doi: 10.1245/s10434-008-0122-9. Epub 2008 Sep 3.

PMID:
18766405
15.
16.

Biomarkers characterization of circulating tumour cells in breast cancer patients.

Nadal R, Fernandez A, Sanchez-Rovira P, Salido M, Rodríguez M, García-Puche JL, Macià M, Corominas JM, Delgado-Rodriguez M, Gonzalez L, Albanell J, Fernández M, Solé F, Lorente JA, Serrano MJ.

Breast Cancer Res. 2012 May 3;14(3):R71.

17.

TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients.

Yoon SO, Kim YT, Jung KC, Jeon YK, Kim BH, Kim CW.

Lung Cancer. 2011 Feb;71(2):209-16. doi: 10.1016/j.lungcan.2010.04.017. Epub 2010 May 14.

PMID:
20471712
18.

[Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].

Wojtacki J, Kruszewski WJ, Sliwińska M, Kruszewska E, Hajdukiewicz W, Sliwiński W, Rolka-Stempniewicz G, Góralczyk M, Leśniewski-Kmak K.

Przegl Lek. 2001;58(6):498-503. Polish.

PMID:
11816740
19.

Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.

Botteri E, Sandri MT, Bagnardi V, Munzone E, Zorzino L, Rotmensz N, Casadio C, Cassatella MC, Esposito A, Curigliano G, Salvatici M, Verri E, Adamoli L, Goldhirsch A, Nolè F.

Breast Cancer Res Treat. 2010 Jul;122(1):211-7. doi: 10.1007/s10549-009-0668-7. Epub 2009 Dec 6.

PMID:
19967556
20.

A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.

Kim SJ, Masago A, Tamaki Y, Akazawa K, Tsukamoto F, Sato J, Ozawa T, Tsujino Y, Noguchi S.

Breast Cancer Res Treat. 2011 Aug;128(3):765-73. doi: 10.1007/s10549-011-1603-2. Epub 2011 Jun 1.

PMID:
21630023

Supplemental Content

Support Center